234 related articles for article (PubMed ID: 16773719)
21. [Malabsorption syndrome. Rare differential diagnosis in a young patient].
Bitzer M; Kaiserling E; Horger MS; Nehls O; Porschen R; Gregor M; Klump B
Internist (Berl); 2004 Feb; 45(2):211-5. PubMed ID: 14991163
[TBL] [Abstract][Full Text] [Related]
22. Immunoproliferative small intestinal disease in Greece: presentation of 13 cases including two from Albania.
Economidou I; Manousos ON; Triantafillidis JK; Vaslamatzis MM; Zafiropoulou R; Papadakis T
Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):1029-38. PubMed ID: 16894320
[TBL] [Abstract][Full Text] [Related]
23. Expression of BCL-6 protein and CD138/syndecan-1 as B-cell markers in Hodgkin's disease.
Carbone A; Gloghini A; Gaidano G
Int J Biol Markers; 1999; 14(3):144-8. PubMed ID: 10569135
[No Abstract] [Full Text] [Related]
24. Immunoproliferative small intestinal disease in a 16-year-old boy presenting as severe malabsorption with excellent response to tetracycline treatment.
Zamir A; Parasher G; Moukarzel AA; Guarini L; Zeien L; Feldman F
J Clin Gastroenterol; 1998 Jul; 27(1):85-9. PubMed ID: 9706780
[TBL] [Abstract][Full Text] [Related]
25. Immunoproliferative small-intestinal disease. An immunohistochemical study.
Isaacson PG; Dogan A; Price SK; Spencer J
Am J Surg Pathol; 1989 Dec; 13(12):1023-33. PubMed ID: 2512818
[TBL] [Abstract][Full Text] [Related]
26. Immunoproliferative small intestinal disease associated with Campylobacter jejuni.
Lecuit M; Abachin E; Martin A; Poyart C; Pochart P; Suarez F; Bengoufa D; Feuillard J; Lavergne A; Gordon JI; Berche P; Guillevin L; Lortholary O
N Engl J Med; 2004 Jan; 350(3):239-48. PubMed ID: 14724303
[TBL] [Abstract][Full Text] [Related]
27. [Assessment of prognostic value of some antigens: p53, bcl-2 and syndecan-1 in laryngeal cancer as well as determination of the usefulness of these antigens in presenting response to cisplatinum in primary cellular cultures of laryngeal cancer].
Klatka J
Otolaryngol Pol; 2003; 57(5):765-8. PubMed ID: 14994627
[No Abstract] [Full Text] [Related]
28. BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma.
Braaten KM; Betensky RA; de Leval L; Okada Y; Hochberg FH; Louis DN; Harris NL; Batchelor TT
Clin Cancer Res; 2003 Mar; 9(3):1063-9. PubMed ID: 12631608
[TBL] [Abstract][Full Text] [Related]
29. [Non-Mediterranean lymphoma producing heavy alpha chains].
Menárguez Palanca J; Tardío Dovao JC; Pérez Fernández R
Med Clin (Barc); 1989 Nov; 93(14):543-5. PubMed ID: 2516185
[TBL] [Abstract][Full Text] [Related]
30. Immunoproliferative small intestinal disease in South India: a clinical and immunomorphological study.
Nair S; Mathan M; Ramakrishna BS; Mathan VI
J Gastroenterol Hepatol; 1998 Dec; 13(12):1207-11. PubMed ID: 9918427
[TBL] [Abstract][Full Text] [Related]
31. Immunoproliferative Small Intestinal Disease Diagnosed by Double-balloon Endoscopy with Biopsy Sampling.
Meza MRR; Nakamura M; Yamamura T; Maeda K; Sawada T; Ishikawa E; Kakushima N; Furukawa K; Ohno E; Honda T; Kawashima H; Ishigami M
Intern Med; 2022 Sep; 61(17):2593-2599. PubMed ID: 35135924
[TBL] [Abstract][Full Text] [Related]
32. Immunoproliferative small intestinal disease: case report and literature review.
Trotman BW; Pavlick AC; Igwegbe IC; Goldstein MM
J Assoc Acad Minor Phys; 1999; 10(4):88-93. PubMed ID: 10826015
[TBL] [Abstract][Full Text] [Related]
33. "Mediterranean abdominal lymphoma" or immunoproliferative small intestinal disease. Part II: pathological aspects.
Nassar VH; Salem PA; Shahid MJ; Alami SY; Balikian JB; Salem AA; Nasrallah SM
Cancer; 1978 Apr; 41(4):1340-54. PubMed ID: 416903
[TBL] [Abstract][Full Text] [Related]
34. [Libyan patient with chronic diarrhea].
Mezger J; Malfertheiner P; Glasmacher A; Breuer TH; Fischer HP; Meybehm M; Kipnowski HJ; Sauerbruch T
Z Gastroenterol; 1996 Oct; 34(10):699-703. PubMed ID: 9012223
[TBL] [Abstract][Full Text] [Related]
35. Characterization of genetic lesions in apoptosis-regulating and proliferation control genes in diffuse large B-cell non-Hodgkin's lymphoma.
Pervez S; Nasir MI; Moatter T; Ahsan A; Haq A; Siddiqui T
J Cancer Res Ther; 2009; 5(4):254-62. PubMed ID: 20160358
[TBL] [Abstract][Full Text] [Related]
36. Differential immunohistochemical expression of syndecan-1 and tumor necrosis factor alpha in colonic mucosa of patients with Crohn's disease.
Principi M; Day R; Marangi S; Burattini O; De Francesco V; Ingrosso M; Pisani A; Panella C; Forbes A; Di Leo A; Francavilla A; Ierardi E
Immunopharmacol Immunotoxicol; 2006; 28(2):185-95. PubMed ID: 16873088
[TBL] [Abstract][Full Text] [Related]
37. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
[TBL] [Abstract][Full Text] [Related]
38. Immunoproliferative small intestinal disease in Mexico. Report of four cases and review of the literature.
Arista-Nasr J; González-Romo MA; Mantilla-Morales A; Lazos-Ochoa M; Ortiz-Hidalgo C
J Clin Gastroenterol; 1994 Jan; 18(1):67-71. PubMed ID: 8113590
[TBL] [Abstract][Full Text] [Related]
39. Elevated serum IgA associated with immunoproliferative enteropathy of Basenji dogs: lack of evidence for alpha heavy-chain disease or enhanced intestinal IgA secretion.
De Buysscher EV; Breitschwerdt EB; MacLachlan NJ
Vet Immunol Immunopathol; 1988 Dec; 20(1):41-52. PubMed ID: 3149068
[TBL] [Abstract][Full Text] [Related]
40. Immunoproliferative small intestinal disease: prolonged 30-year course without development of lymphoma.
Lin OS; Gray GM
Am J Gastroenterol; 2001 Sep; 96(9):2769-74. PubMed ID: 11569710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
